
Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
Author(s) -
Chen-Yang Zhao,
Zhao Cui,
Yi-Miao Zhang,
Fang Wang,
Xin Wang,
Xuyang Cheng,
Liqiang Meng,
Gang Liu,
MingHui Zhao
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001855
Subject(s) - minimal change disease , prednisone , medicine , leflunomide , focal segmental glomerulosclerosis , nephrotic syndrome , gastroenterology , adverse effect , urology , endocrinology , glomerulonephritis , methotrexate , kidney